Global Presence
EIPICO Headquarters was first established at the Heart of the World in Egypt and expanded over the decades to reach people from the far east to the west.
EIPICO is Globally Present in 65 countries with ambitious strategic plan reaching 100 Countries by 2025.
Read more
► Countries Active In Sales & Marketing
► Targeted Countries For Marketing
EIPICO strongly believes that delivering High-Quality Pharmaceutical Products to every Patient at affordable prices is a basic human right.
We achieve this through:
Commitment
EIPICO’s pursuit of Healthcare Services Expansion Reaching Patients in Low-income Countries is a top priority.
Strategy
EIPICO Serves Patients Worldwide through all business integration models not only by the Collaboration with Local Pharmaceutical Importing and Distributing companies but also through exporting Semifinished Contract Manufacturing Products & Finished Under license Agreement Products.
Diversity
EIPICO exploits its Facilities and Human Capabilities to improve patient’s Quality of life by Covering more than 25 therapeutic disease area and 1300 different product registered worldwide.
Capacity
-Production Capacity units
-Operation management & efficiency
EIPICO manufactures more than 400 Pharmaceutical Products covering 24 Therapeutic Groups. Moreover, we have a keen sense of market dynamics. Thus, always introducing products matching customer needs e.g. Epizithro, Epicare, Gufidrexn & Epicopred.
EIPICO is trusted for its high-quality standards, that’s why EIPICO is producing many products for multinational companies.
EIPICO holds License Agreements with a group of international pharmaceutical companies to produce their products locally.
EIPICO is currently the Largest Provider of Antibiotics, Lyophilized Products and Spansule Capsules to the Egyptian market.
EIPICO produces novel
dosage forms, such as
Spansule capsules &
non-traditional dosage
forms, e.g. soft gelatin
capsules, lyophilized
products, gels, sprayers
& effervescent tablets
EIPICO produces many
of the Covid-19 related
protocol medicines:
Epicehin, Epizithro,
Cetal, Dexamethasone,
Cevitil
EIPICO was awarded the
ISO - 9001 for Quality
Assurance excellence.
EIPICO is an eco-friendly
company & was
awarded ISO - 14001 for
environmentally friendly
practices.
EIPICO captures significant market share in many therapeutic areas
 | Anti-Infective |
 | CVS system |
 | Analgesics &
Anti-inflammatory |
 | Dermatological |
 | Systemic sex
hormones |
 | Alimentary,
Metabolism |
 | Respiratory
system |
 | Ophthalmics |
|
EIPICO has an outstanding Performance in the Egyptian Market
EIPICO is ranked no. 1 in Systemic Anti-Infectives Market by units
(Source: IQVIA, MAT, 09, 20)
EIPICO is ranked no. 1 in Ophthalmics Market by units
(Source: IQVIA, MAT, 09, 20)
Global Accreditation
EIPICO implements all the quality standards to ensure that its products provide competitive advantages in efficacy, safety and price, worldwide.
EIPICO premises undergo regular inspections by different foreign health authorities.
EIPICO was certified and recognized as Quality Manufacturer by MHRA UK, PICs, WHO prequalified Lines, GCC, Ukrainian GMP, Romanian GMP, NFDAC, Ugandan GMP, and Ghanaian FDA authorities.